glp-1 compound podcast Hub: Support, Community, and Weight Loss FDA cracks down on 'misleading'

The trend is clear: employers are no longer willing to accept aggregated rebate summaries as evidence of value

Your healthcare team can help you develop a comprehensive plan that includes medication along with lifestyle changes

Recent studies have raised concerns about a higher risk of gastroparesis in GLP-1 medication users

Critical limitations include: Heterogeneity : Different strains, doses, and formulations make comparisons difficult Small effect sizes : Weight changes are typically modest and may not be clinically significant Short duration : Most studies last 12 weeks or less, providing no data on sustained effects Publication bias : Negative studies may be underreported There is no high-quality evidence that probiotic supplements can replicate the substantial weight loss achieved with prescription medications like semaglutide or tirzepatide